Proceedings: A new possibility to treat superficial eye injuries with an ointment, presenting the advantages, but not the disadvantages of local application of corticosteroids. A double-blind trial in the effect of oxyphenbutazone 10 percent eye ointment (Tanderil) as a therapy in superficial eye injuries.
D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005129:Eye Foreign Bodies; D005131:Eye Injuries / Q000188:drug therapy*; D005260:Female; D005549:Foreign-Body Reaction / Q000188:drug therapy; D005938:Glucocorticoids; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D008297:Male; D009824:Ointments; D010113:Oxyphenbutazone / Q000008:administration & dosage* / Q000627:therapeutic use; D010919:Placebos
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D009824:Ointments; D010919:Placebos; D010113:Oxyphenbutazone